As of Sep 29
| -0.07 / -4.43%|
The 4 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 1.50, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a -0.66% decrease from the last price of 1.51.
The current consensus among 7 polled investment analysts is to Hold stock in Infinity Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.